REQUEST A DEMO
Total
USD $0.00
Search more companies

Deva Holding A.S. (Turkiye)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Deva Holding Anonim Sirketi Profile Updated: October 08, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

DEVA Holding Anonim Sirketi, located in Istanbul, is a well-established pharmaceutical manufacturer in Turkey. Established in 1958, the company specializes in manufacturing and marketing medicinal products for human and veterinary use, as well as raw materials. They also produce eau de Cologne, medical ampoules, and veterinary medicines. In 2006, the majority of shares in DEVA Holding were acquired by funds managed by GEM Global Equities Management S.A. and EastPharma Ltd. was established to manage the company. DEVA Holding aims to be the first choice by offering innovative and unique products of high quality. They have a diverse product portfolio of over 650 products in 14 therapeutic areas, including oncology, cardiology, respiratory system, ophthalmology, and medical devices. DEVA Holding holds 1,029 marketing authorizations in 69 countries, including the USA, Switzerland, and Germany. The company focuses on research and development to improve access to medicines and all manufacturing facilities are compliant with European GMP and US FDA standards. DEVA Holding exports pharmaceuticals and raw materials to over 50 countries. They have comprehensive production capabilities in Turkey and operate manufacturing facilities in Çerkezköy and Kartepe with an annual output capacity of 578 million units of medicines. DEVA Holding is committed to sustainability and considers environmental sensitivities in its activities. The company also supports social responsibility projects in education, public health, and the environment. Their mission is to offer innovative and diversified products for a healthy life, while their vision is to become the first choice in their competitive areas by creating strong pharmaceutical brands.

Legal Address
Halkali Merkez District, Basin Ekspres Street No:1, Kucukcekmece
Istanbul; Marmara; Postal Code: 34303

Contact Details: Purchase the Deva Holding A.S. report to view the information.

Website: http://www.deva.com.tr/en

Basic Information
Total Employees:
Purchase the Deva Holding A.S. report to view the information.
Outstanding Shares:
Purchase the Deva Holding A.S. report to view the information.
Registered Capital:
Purchase the Deva Holding A.S. report to view the information.
Financial Auditors:
Purchase the Deva Holding A.S. report to view the information.
Incorporation Date:
August 22, 1958
Key Executives
Purchase this report to view the information.
Chairman
Purchase this report to view the information.
Chief Financial Officer
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Purchase this report to view the information.
Director/Member of the Board
Ownership Details
Purchase this report to view the information.
82.2%
Purchase this report to view the information.
17.8%
Subsidiaries
Devatis A.G (Switzerland)
Devatis D.O.O Beograde
Devatis De Mexico (Mexico)
Company Performance
Financial values in the chart are available after Deva Holding A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
78.85%
Total operating revenue
84.68%
Operating profit (EBIT)
-80%
EBITDA
3.48%
Net Profit (Loss) for the Period
N/A
Total assets
148.32%
Total equity
275.01%
Operating Profit Margin (ROS)
-33.33%
Net Profit Margin
N/A
Return on Equity (ROE)
N/A
Debt to Equity Ratio
-57.66%
Quick Ratio
0.23%
Cash Ratio
0.04%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?